REFERENCES
- Alkalay AL, Mazkereth R, Santulli T, Pomerance JJ. Central venous line thrombosis in premature infants: a case management and literature review. Am J Perinatol. 1993;10:323–326.
- John JB, Cron SG, Kung GC, Mott AR. Intracardiac thrombi in pediatric patients: presentation profiles and clinical outcomes. Pediatr Cardiol. 2007;28:213–220.
- Mendoza GJ, Soto A, Brown EG, Intracardiac thrombi complicating central parenteral nutrition: resolution without surgery or thrombolysis. J Pediatr. 1986;108:610–613.
- Bendaly EA, Batra AS, Ebenroth ES, Hurwitz RA. Outcome of cardiac thrombi in infants. Pediatr Cardiol. 2008;29:95–101.
- Dix D, Andrew M, Marzinotto V. The use of low molecular weight heparin in pediatric patients: a prospective cohort study. J Pediatr. 2000;136:439–445.
- Farnoux C, Camard O, Pinquier D. Recombinant tissue-type plasminogen activator therapy of thrombosis in 16 neonates. J Pediatr. 1998;133:137–140.
- Giuffre B, Compagnoni G, Farina C, Mosca F. Successful use of tissue plasminogen activator (t-PA) in catheter-related intracardiac thrombi of two premature infants. Acta Paediatr. 1998;87:695–698.
- Chalmers EA. Thrombolytic therapy in themanagement of paediatric thromboembolic disease. Br J Haematol. 1999;104:14–21.
- Atalay S, Akar N, Tutar HE, 1691 G-A mutation in children with intracardiac thrombosis: a prospective study. Acta Paediatr. 2002;91:168–171.
- Payne JH. Aspects of anticoagulation in children. Br J Haematol. 2010;150:259–277.
- Gürgey A, Özyürek E, Gümrük F. Thrombosis in children with cardiac pathology: frequency of factor V Leiden and prothrombin G20210A mutations. Pediatr Cardiol. 2003;24:244–248.
- Özkutlu S, Özbarlas N, Özme Ş, Intracardiac thrombosis diagnosed by echocardiography in childhood: predisposing and etiological factors. Int J Cardiol. 1993;40:251–256.
- Yang JY, Williams S, Brandao LR, Chan AK. Neonatal and childhood right atrial thrombosis: recognition and a risk-stratified treatment approach. Blood Coagul Fibrinolysis. 2010;21:301–307.
- Rimensberger PC, Humbert JR, Beghetti M. Management of preterm infants with intracardiac thrombi: use of thrombolytic agents. Paediatr Drugs. 2001;3:883–898.
- Streif W, Goebel G, Chan AK, Massicotte MP. Use of low molecular mass heparin (enoxaparin) in newborn infants: a prospective cohort study of 62 patients. Arch Dis Child Fetal Neonatal Ed. 2003;88:F365–F370.
- Klinger G, Hellmann J, Daneman A. Severe aortic thrombosis in the neonate: successful treatment with low-molecular-weight heparin: two case reports and review of the literature. Am J Perinatol. 2000;17:151–158.
- Michaels LA, Gurian M, Hegyi T, Drachtman RA. Low molecular weight heparin in the treatment of venous and arterial thromboses in the premature infant. Pediatrics. 2004;114:703–707.
- Punzalan RC, Hillery CA, Montgomery RR, Low-molecular-weight heparin in thrombotic disease in children and adolescents. J Pediatr Hematol Oncol. 2000;22:137–142.
- Schepper JD, Hachimi-Idrissi S, Cham B. Diagnosis and management of catheter-related infected intracardiac thrombosis in premature infants. Am J Perinatol. 1993;10:39–42.